Mark Anderson, MD
Cardiovascular Disease · Oklahoma City, OKNPI 1184030439
Payments from drug & device makers
What this record shows
That places this record below the midpoint for cardiovascular disease clinicians in OK, where the typical reported total is $2,806.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 28 payments — averaging $4034.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$113K
How this compares
$0 in reported general payments places this provider in the 0th percentile of 164 cardiovascular disease providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 678 | $573,981 |
| EntrestoSacubitril/Valsartan | 182 | $169,306 |
| XareltoRivaroxaban | 167 | $148,547 |
| JardianceEmpagliflozin | 97 | $63,919 |
| BrilintaTicagrelor | 39 | $28,012 |
| Repatha SureclickEvolocumab | 39 | $25,600 |
| Praluent PenAlirocumab | 22 | $10,915 |
| Metoprolol Succinate | 489 | $7,609 |
| Rosuvastatin Calcium | 362 | $5,314 |
| Ranolazine ErRanolazine | 39 | $5,291 |
| Atorvastatin Calcium | 376 | $4,872 |
| Potassium Chloride | 229 | $3,679 |
| Amlodipine Besylate | 397 | $3,337 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 14 | $3,293 |
| ClopidogrelClopidogrel Bisulfate | 220 | $2,727 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Oklahoma City
- Aly El BanayosyOklahoma City$54K
- Dwight ReynoldsOklahoma City$47K
- Udho ThadaniOklahoma City$41K
- Robert SullivanOklahoma City$36K
- Reji PappyOklahoma City$25K
- Sandeep ChopraOklahoma City$15K
- Jered CookOklahoma City$14K
- William CollazoOklahoma City$11K
- Vinodh JeevananthamOklahoma City$11K
- Niraj PrasadOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.